Eli Lilly says its monoclonal antibody cocktail is effective in treating Covid-19https://www.statnews.com/2020/10/07/eli-lilly-monoclonal-antibody-cocktail-covid-19/Eli Lilly said Wednesday a monoclonal antibody treatment is effective in reducing levels of the virus that causes Covid-19 in patients, and also appears to prevent patients from visiting the emergency room or hospital.
Lilly had previously released results for a similar treatment using one antibody, which experts viewed as promising. But the new results, of a combination of two antibodies, appear, based on limited data provided in a press release, to be more robust. The results also appear roughly similar to those Regeneron presented last week of its own cocktail of two monoclonal antibodies. Last Friday, President Trump was treated with the Regeneron monoclonal antibodies.
Lilly's partner, AbCellera, which is also a partner in a DARPA project, began working on this on January 28th.
